Catalyst Bio (CBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBIO | KAPA | AFMD | ||
| Company | Catalyst Bio | Kairos Pharma Ltd | Affimed N.V. | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE Arca | NASDAQ | ||
| Open | 8.4990 | 1.6900 | 1.1800 | ||
| High | 8.6940 | 1.7400 | 1.2500 | ||
| Low | 7.2000 | 1.5600 | 1.1438 | ||
| Last | 7.6695 | 1.5700 | 1.1900 | ||
| Change | -0.2085 | -0.1200 | +0.0100 | ||
| % Change | -2.65% | -7.10% | +0.85% | ||
| Volume | 32,246 | 84,000 | 419,300 | ||
| 20-Day Average Volume | 378,990 | 92,775 | 558,975 | ||
| Previous Close | 7.8780 | 1.6900 | 1.1800 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 0.4494 | 1.6022 | 2.2570 | ||
| 20-Day Raw Stochastic | 71.38% | 40.68% | 2.36% | ||
| 20-Day Relative Strength | 54.01% | 46.72% | 19.10% | ||
| Weighted Alpha | +18.13 | N/A | -78.11 | ||
| Today's Opinion | 88% Buy | N/A | 100% Sell | ||
| Previous Opinion | 88% Buy | N/A | 100% Sell | ||
| Last Month's Opinion | 88% Buy | N/A | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +9.72% since 10/23/23 | -7.65% since 12/13/24 | -44.65% since 12/13/24 | ||
| Low | 0.3720 on 10/24/23 | 1.5600 on 12/20/24 | 1.1438 on 12/20/24 | ||
| High | 0.5800 on 10/27/23 | 1.7800 on 12/16/24 | 2.2100 on 12/16/24 | ||
| 1-Month | |||||
| %Chg | +6.01% since 09/29/23 | +7.53% since 11/20/24 | -56.25% since 11/20/24 | ||
| Low | 0.3200 on 10/13/23 | 1.3300 on 12/09/24 | 1.1438 on 12/20/24 | ||
| High | 0.5880 on 10/20/23 | 1.9200 on 12/13/24 | 3.0982 on 11/25/24 | ||
| 3-Month | |||||
| %Chg | +36.38% since 07/28/23 | -28.31% since 09/20/24 | -67.75% since 09/20/24 | ||
| Low | 0.3200 on 10/13/23 | 1.2200 on 10/01/24 | 1.1438 on 12/20/24 | ||
| High | 0.7400 on 08/23/23 | 2.7500 on 11/13/24 | 4.0413 on 11/14/24 | ||
| 6-Month | |||||
| %Chg | +141.18% since 04/28/23 | N/A since 09/16/24 | -79.83% since 06/20/24 | ||
| Low | 0.2000 on 05/01/23 | 1.2200 on 10/01/24 | 1.1438 on 12/20/24 | ||
| High | 0.7400 on 08/23/23 | 4.0000 on 09/16/24 | 6.2403 on 06/24/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 19,418 | 20,170 | 19,159 | ||
| Shares Outstanding, K | 37,978 | 12,847 | 16,100 | ||
| Annual Sales | 790,000 | 0 | 8,960,000 | ||
| Annual Net Income | -8,240,000 | -1,812,000 | -114,660,000 | ||
| Last Quarter Sales | 0 | 0 | 170,000 | ||
| Last Quarter Net Income | -1,580,000 | -1,047,000 | -16,650,000 | ||
| 60-Month Beta | 1.05 | N/A | 2.06 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.04 on 10/26/23 | -0.10 on 11/14/24 | -1.03 on 11/14/24 | ||
| Latest Earnings Date | 11/13/23 | 02/13/25 | 11/14/24 | ||
| Most Recent Dividend | 0.569 on 08/20/15 | N/A | N/A | ||
| Next Ex-Dividends Date | 08/20/15 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||